Literature DB >> 27521879

Total Laparoscopic Hysterectomy and Laparoscopic-Assisted Vaginal Hysterectomy.

Cara R King1, Dobie Giles2.   

Abstract

Vaginal hysterectomy has been shown to have the lowest complication rate, better cosmesis, and decreased cost compared with alternate routes of hysterectomy. However, there are times when a vaginal hysterectomy is not feasible and an open abdominal hysterectomy should be avoided. Minimally invasive surgery has evolved over the last several decades; with the improvement in optics and surgical instruments, laparoscopic hysterectomy is becoming increasingly common. A total laparoscopic hysterectomy is possible with proper training, including sound technique in laparoscopic suturing for closure of the vaginal cuff.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  Laparoscopic assisted vaginal hysterectomy; Laparoscopic hysterectomy; Laparoscopy; Minimally invasive surgery; Vaginal surgery

Mesh:

Year:  2016        PMID: 27521879     DOI: 10.1016/j.ogc.2016.04.005

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  3 in total

1.  Robotic transvaginal natural orifice transluminal endoscopic surgery for bilateral salpingo oophorectomy.

Authors:  Lior Lowenstein; Emad Matanes; Zeev Weiner; Jan Baekelandt
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2020-06-23

2.  Quality of life in patients who undergo conventional or robotic-assisted total laparoscopic hysterectomy: Protocol for a systematic review of randomized controlled trials.

Authors:  Rodrigo Corvino Rodrigues; Meline Rossetto Kron Rodrigues; Noélle de Oliveira Freitas; Marilza Vieira Cunha Rudge; Silvana Andréa Molina Lima
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

3.  Clinical value of traditional laparotomy, extensive vaginal hysterectomy, and laparoscope-assisted vaginal hysterectomy in the treatment of patients with cervical intraepithelial neoplasia III.

Authors:  Yao Xu; Haiyan Wu; Chaolin Huang; Ling Lu
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.